IMM-H007 nacipran Smiles: CC(C)(C)OC(=O)NC1CCCCCC=C[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1CC2=C(C1)C=CC=C2F)C(=O)NS(=O)(=O)C1CC1 |c:14|

Smiles: CC(C)(C)OC(=O)NC1CCCCCC=C[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1CC2=C(C1)C=CC=C2F)C(=O)NS(=O)(=O)C1CC1 |c:14|

ZYAN1-1001)

A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase

such as mucosal erosions or leakage in the KI mice or nonhuman primates

IMM-H007 nacipran Smiles: CC(C)(C)OC(=O)NC1CCCCCC=C[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1CC2=C(C1)C=CC=C2F)C(=O)NS(=O)(=O)C1CC1 |c:14|IMM H007, an adenosine derivative, is an activator of AMP Activated Protein Kinase (AMPK). IMM H007 is a potential drug for treating cardiac dysfunction. IMM H007 negatively regulates endothelium inflammation through inactivating NF B and JNK AP1 signaling. IMM H007 inhibits ABCA1 (ATP binding cassette subfamily a member 1) degradation and facilitates its cell surface localization in macrophages, thereby promotes cholesterol efflux. Product